Jennifer J. Rhodes - Dec 14, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Signature
/s/ Jennifer J. Rhodes
Stock symbol
ELTX
Transactions as of
Dec 14, 2021
Transactions value $
-$1,090
Form type
4
Date filed
12/15/2021, 03:06 PM
Previous filing
Nov 16, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale -$1.09K -451 -1.46% $2.42* 30.4K Dec 14, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.41 to $2.42 inclusive.

Remarks:

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary